Skip to main content
Premium Trial:

Request an Annual Quote

Genomica to Develop Celera Edition of its Software

NEW YORK, April 30 - Genomica said Monday it would develop a “Celera Edition” of its Discovery Manager software to work in conjunction with Celera’s SNP Reference Database.

Genomica of Boulder, Colo., did not disclose financial terms of the deal.

Under the terms of the deal, customers of the SNP database and of Discovery Manager will be able to “seamlessly” use the software to manage analyze Celera’s SNP data, Genomica said. Discovery Manager will also have a link to the Celera database, allowing users to create web-based SNP reports.

"This agreement with Genomica gives researchers an advantage in gathering, organizing and analyzing SNP data," James Peck, Celera's senior vice president of product development, said in a statement. 

Last September, Celera’s sister company,  Applied Biosystems, made a $3 million equity investment in software developer Genomica. At the time, Genomica also agreed to license its genetic-analysis object model to Applied Biosystems. 

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.